Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Disposition of [14C]ABT-869 in Patients With Solid Tumors Following a Single Oral Dose Administration

NCT01286974 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT01286974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01286974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Disposition of [14C]ABT-869 in Patients With Solid Tumors Following a Single Oral Dose Administration
Lead sponsor
Abbott
Phase
Phase 1
Overall status
Terminated
Start date
August 31, 2011
Completion date
September 30, 2012
Enrollment
3 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors